That essentially means the globally popular vaccines, which their makers have pledged not to sell to private parties during the pandemic, will not be available for now in the world’s two most populous countries – China and India. The Indian government has also declined to meet the U.S. companies’ requests for legal protection over any side-effects from the use of their shots, which are currently made only in the United States or Europe, two of the sources said.